Dr. Benjamin is the Kiser-Arena Distinguished Professor of Pediatrics at Duke University, adjunct professor of epidemiology at the University of North Carolina School of Public Health, and adjunct professor of pharmacy at the University of North Carolina School of Pharmacy. Dr. Benjamin has active NIH-sponsored research in clinical pharmacology, therapeutics, trials, and pharmacoepidemiology. He is the author of more than 200 peer-reviewed publications. He has led or is leading more than 20 clinical trials for FDA labeling, and his annual research budget is $15,000,000. He is the principal investigator and chair for the Pediatric Trials Network (PTN), an NICHD-sponsored initiative to study off-patent therapeutics in children of all ages. In that role, he has broad oversight of 5–7 multicenter trials and 3–6 pharmacoepidemiology projects each year. He recruits the protocol chair for each project and oversees selection of all team members and operations staff. In addition to his research activities, Dr. Benjamin has a track record for dedication to mentorship and education of trainees at all levels. He is the PI of a K24 (NICHD) grant and co-PI of a T32 (NIGMS) grant, as well as faculty mentor for four faculty mentees supported by the NIH.